U.S., Dec. 6 -- ClinicalTrials.gov registry received information related to the study (NCT07265778) titled 'Clinical Investigation for Evaluating the Safety and Efficacy of JTM102 to Mid Face Volume Deficiency' on Nov. 24.
Brief Summary: This study is clinical investigation for evaluating safety and efficacy of JTM102 on temporary correction of mid-face volume deficiency
Study Start Date: Oct. 22, 2024
Study Type: INTERVENTIONAL
Condition:
Mid Face Volume Deficit
Intervention:
DEVICE: JTM102
Sodium Hyaluronate 20mg/ml Lidocaine Hydrochloride 03.%
DEVICE: Juvederm VOLUMA with Lidocaine
Sodium Hyaluronate 20mg/ml Lidocaine Hydrochloride 0.3%
Recruitment Status: ACTIVE_NOT_RECRUITING
Sponsor: Jetema Co., Ltd.
Disclaimer: Curated b...